The call, on record
HIMS bullish call
Quoted text as recorded“And if that's the case, if we get 50% plus growth and that's what they're guiding for for the second half of 2026, I think this company deserves to trade for a lot more than 3.3 times sales.”@ 23:21 · open at this moment on YouTube ↗
Our interpretation
- Source published
- Jul 24, 2026
- Timeframe
- If growth reaches 50% or more and guidance supports that rate for the second half of 2026
- Extracted deadline
- Dec 31, 2026
- Interpreted confidence
- low
- Specificity
- specific
Email me when HIMS calls resolve
When a tracked HIMS call is scored — hit, miss or partial — we’ll email you the result. No account needed.
Used only for these updates. Privacy
Our summary of the thesis
Strongly BullishStructured interpretation of the video, not a verbatim quotation. Check the source for conditions, emphasis and context.
He sees Hims as a potentially large global healthcare platform built around direct consumer relationships, subscriptions, and personalized treatment. He expects a higher valuation if second-half growth accelerates, while describing the long-term investment as a high-upside, potentially binary outcome.
Key arguments
- Subscriber growth could reaccelerate after difficult comparisons.
- Weight-loss customers can increase average revenue per subscriber.
- A 50% or greater second-half growth rate could warrant a higher sales multiple.
- Global brand consolidation, lab services, and consumer data could deepen relationships.
- Specialized healthcare relationships may be more durable than general retail offerings.
Counter-arguments acknowledged
- The growth and guidance catalysts remain unconfirmed.
- He allows that his view of specialized healthcare platforms could be wrong.
- The company could ultimately fail rather than realize its upside.
Hedges and caveats (from the video)
- He does not make short-term price projections and cannot predict earnings reactions or when market sentiment will change.
- Several holdings could remain dead money for years before their theses are recognized.
- Autonomous-driving commercialization is developing more slowly than anticipated.
- Hims and Joby have substantial execution risk and potentially binary long-term outcomes.
- His Tesla put position is risky and its initial timing was poor.
- He has not fully reviewed several earnings calls and declines firm opinions on businesses outside his expertise.
- AI infrastructure profitability depends on uncertain future demand, pricing, financing costs, and returns on capital.
About this record
Not yet reviewed by a moderatorImported analysis · scheduled AI source. A quote, summary and outcome each need their own context. Moderator review does not certify investment performance.
- Source published
- Jul 24, 2026, 4:45 AM UTC
- First recorded by TubeRank
- Nov 2, 2026, 6:25 AM UTC
- Record last updated
- Nov 2, 2026, 6:25 AM UTC
- Moderator review recorded
- Not recorded
- Transcript provenance
- YouTube captions (manual or automatic)
- Recorded analysis processor/source label
- codex-cli-scheduled
- This can identify a workflow rather than an exact AI model version.
- Submission path version
- manual_v1
- Identifies the precomputed submission path. It does not identify an AI model version or imply human authorship.
- Outcome methodology version
- Not recorded; not audited under current rules
Recent record changes 1 shown
Nov 2, 2026, 6:25 AM UTC
source updated
- Recorded analysis processor/source label
BeforeNot recorded
Aftercodex-cli-scheduled
- Extraction or submission version
BeforeNot recorded
Aftermanual_v1
Showing up to 20 recent changes. The complete feed has 2 recorded events for this call, including its initial entry. Read the full paginated history (JSON); follow nextCursor while hasMore is true.
Stored outcome evidence
- Stored reference price
- Not recorded
- Not recorded · provider not recorded
- Target as extracted
- Not recorded
- Stated deadline as extracted
- Dec 31, 2026
- Recorded outcome date
- Not recorded
- Outcome price observation
- Not recorded
- Not recorded · provider not recorded
Stored explanation
No explanation was recorded for this outcome.
Missing timestamps, providers and versions are historical gaps. Stored observations can include daily closes; they do not show every intraday touch or prove an executable trade. Read the methodology.
Why we interpreted the confidence this way
The valuation upside is explicitly conditional on reported growth and guidance; the growth period does not establish a firm stock-price deadline.